Symyx Board Again Rejects Certara Bid

Symyx's board has rejected Certara's bid for the second time this week and has urged shareholders to vote in favor of a deal with Accelrys.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories